Copy number variation in autoimmunity - importance hidden in complexity?

European Journal of Immunology

Volumn 42, Issue 8, 2012, Pages 1969-1976

  Olsson, Lina M ^a   Holmdahl, Rikard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Autoimmunity; Copy number variation; Deletion; Duplication

Indexed keywords

BETA DEFENSIN; COMPLEMENT COMPONENT C4; CXCL3 CHEMOKINE; FC RECEPTOR; GUANOSINE TRIPHOSPHATASE;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; COPY NUMBER VARIATION; DISEASE ASSOCIATION; GENE; GENE DELETION; GENE DUPLICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; GENOTYPE; HUMAN; PRIORITY JOURNAL; REVIEW;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; BETA-DEFENSINS; CHEMOKINES, CC; COMPLEMENT C4; DNA COPY NUMBER VARIATIONS; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME, HUMAN; GPI-LINKED PROTEINS; HUMANS; NADPH OXIDASE; RECEPTORS, IGG;

EID: 84864741741     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242601     Document Type: Review

References (61)

1. Gregersen, P. K. and Olsson, L. M., Recent advances in the genetics of autoimmune disease. Annu. Rev. Immunol. 2009. 27: 363-391.
2. Bailey, J. A., Gu, Z., Clark, R. A., Reinert, K., Samonte, R. V., Schwartz, S., Adams, M. D. et al., Recent segmental duplications in the human genome. Science 2002. 297: 1003-1007.
3. Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., Fiegler, H. et al., Global variation in copy number in the human genome. Nature 2006. 444: 444-454.
4. Nguyen, D. Q., Webber, C. and Ponting, C. P., Bias of selection on human copy-number variants. PLoS Genet. 2006. 2: e20. DOI: 10.1371/journal.pgen.0020020.
5. Martin, M. P., Nelson, G., Lee, J. H., Pellett, F., Gao, X., Wade, J., Wilson, M. J. et al., Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J. Immunol. 2002. 169: 2818-2822.
6. Garcia-Leon, J. A., Pinto-Medel, M. J., Garcia-Trujillo, L., Lopez-Gomez, C., Oliver-Martos, B., Prat-Arrojo, I., Marin-Banasco, C. et al., Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients. Mol. Immunol. 2011. 48: 1896-1902.
7. Conrad, D. F., Pinto, D., Redon, R., Feuk, L., Gokcumen, O., Zhang, Y., Aerts, J., et al., Origins and functional impact of copy number variation in the human genome. Nature 2010. 464: 704-712.
8. Mills, R. E., Walter, K., Stewart, C., Handsaker, R. E., Chen, K., Alkan, C., Abyzov, A. et al., Mapping copy number variation by population-scale genome sequencing. Nature 2011. 470: 59-65.
9. Lee, J. A. and Lupski, J. R., Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron 2006. 52: 103-121.
10. Campbell, C. D., Sampas, N., Tsalenko, A., Sudmant, P. H., Kidd, J. M., Malig, M., Vu, T. H. et al., Population-genetic properties of differentiated human copy-number polymorphisms. Am. J. Hum. Genet. 2011. 88: 317-332.
11. Sudmant, P. H., Kitzman, J. O., Antonacci, F., Alkan, C., Malig, M., Tsalenko, A., Sampas, N. et al., Diversity of human copy number variation and multicopy genes. Science 2010. 330: 641-646.
12. Hurles, M. E., Dermitzakis, E. T. and Tyler-Smith, C., The functional impact of structural variation in humans. Trends Genet. 2008. 24: 238-245.
13. Craddock, N., Hurles, M. E., Cardin, N., Pearson, R. D., Plagnol, V., Robson, S., Vukcevic, D. et al., Genome-wide association study of CNVs in 16, 000 cases of eight common diseases and 3, 000 shared controls. Nature 2010. 464: 713-720.
14. McCarroll, S. A., Huett, A., Kuballa, P., Chilewski, S. D., Landry, A., Goyette, P., Zody, M. C. et al., Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Genet. 2008. 40: 1107-1112.
15. Fanciulli, M., Norsworthy, P. J., Petretto, E., Dong, R., Harper, L., Kamesh, L., Heward, J. M. et al., FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat. Genet. 2007. 39: 721-723.
16. Robinson, J. I., Carr, I. M., Cooper, D. L., Rashid, L. H., Martin, S. G., Emery, P., Isaacs, J. D. et al., Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis. Hum. Mutat. 2012. 33: 741-749.
17. Brest, P., Lapaquette, P., Souidi, M., Lebrigand, K., Cesaro, A., Vouret-Craviari, V., Mari, B. et al., A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat. Genet. 2011. 43: 242-245.
18. Prescott, N. J., Dominy, K. M., Kubo, M., Lewis, C. M., Fisher, S. A., Redon, R., Huang, N. et al., Independent and population-specific association of risk variants at the IRGM locus with Crohn's disease. Hum. Mol. Genet. 2010. 19: 1828-1839.
19. Aitman, T. J., Dong, R., Vyse, T. J., Norsworthy, P. J., Johnson, M. D., Smith, J., Mangion, J. et al., Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006. 439: 851-855.
20. Mamtani, M., Anaya, J. M., He, W. and Ahuja, S. K., Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases. Genes Immun. 2010. 11: 155-160.
21. Morris, D. L., Roberts, A. L., Witherden, A. S., Tarzi, R., Barros, P., Whittaker, J. C., Cook, T. H. et al., Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus. Euro. J. Hum. Genet. 2010. 18: 1027-1031.
22. McKinney, C., Fanciulli, M., Merriman, M. E., Phipps-Green, A., Alizadeh, B. Z., Koeleman, B. P., Dalbeth, N. et al., Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Annals Rheumat. Dis. 2010. 69: 1711-1716.
23. Marques, R. B., Thabet, M. M., White, S. J., Houwing-Duistermaat, J. J., Bakker, A. M., Hendriks, G. J., Zhernakova, A. et al., Genetic variation of the Fc gamma receptor 3B gene and association with rheumatoid arthritis. PLoS One 2010. 5. DOI: 10.1371/journal.pone.0013173x.
24. McKinney, C. and Merriman, T. R., Meta-analysis confirms a role for deletion in FCGR3B in autoimmune phenotypes. Hum. Mol. Genet. 2012. 21: 2370-2376.
25. Hollox, E. J., Armour, J. A. and Barber, J. C., Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am. J. Hum. Genet. 2003. 73: 591-600.
26. Fellermann, K., Stange, D. E., Schaeffeler, E., Schmalzl, H., Wehkamp, J., Bevins, C. L., Reinisch, W. et al., A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am. J. Hum. Genet. 2006. 79: 439-448.
27. Ramasundara, M., Leach, S. T., Lemberg, D. A. and Day, A. S., Defensins and inflammation: the role of defensins in inflammatory bowel disease. J. Gastroenterol. Hepatol. 2009. 24: 202-208.
28. Wehkamp, J., Harder, J., Weichenthal, M., Mueller, O., Herrlinger, K. R., Fellermann, K., Schroeder, J. M. et al., Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm. Bowel Dis. 2003. 9: 215-223.
29. Bentley, R. W., Pearson, J., Gearry, R. B., Barclay, M. L., McKinney, C., Merriman, T. R. and Roberts, R. L., Association of higher DEFB4 genomic copy number with Crohn's disease. Am. J. Gastroenterol. 2010. 105: 354-359.
30. Aldhous, M. C., Abu Bakar, S., Prescott, N. J., Palla, R., Soo, K., Mansfield, J. C., Mathew, C. G. et al., Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease. Hum. Mol. Genet. 2010. 19: 4930-4938.
31. Zhou, X. J., Cheng, F. J., Lv, J. C., Luo, H., Yu, F., Chen, M., Zhao, M. H et al., Higher DEFB4 genomic copy number in SLE and ANCA-associated small vasculitis. Rheumatology 2012. 51: 992-995.
32. Vordenbaumen, S., Timm, D., Bleck, E., Richter, J., Fischer-Betz, R., Chehab, G., Sander, O. et al., Altered serum levels of human neutrophil peptides (HNP) and human beta-defensin 2 (hBD2) in Wegener's granulomatosis. Rheumatol. Internat. 2011. 31: 1251-1254.
33. Vordenbaumen, S., Fischer-Betz, R., Timm, D., Sander, O., Chehab, G., Richter, J., Bleck, E. et al., Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus. Lupus 2010. 19: 1648-1653.
34. Hollox, E. J., Huffmeier, U., Zeeuwen, P. L., Palla, R., Lascorz, J., Rodijk-Olthuis, D., van de Kerkhof, P. C. et al., Psoriasis is associated with increased beta-defensin genomic copy number. Nat. Genet. 2008. 40: 23-25.
35. Berger, E. A., Murphy, P. M. and Farber, J. M., Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Ann. Rev. Immunol. 1999. 17: 657-700.
36. Gonzalez, E., Kulkarni, H., Bolivar, H., Mangano, A., Sanchez, R., Catano, G., Nibbs, R. J. et al., The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005. 307: 1434-1440.
37. Dolan, M. J., Kulkarni, H., Camargo, J. F., He, W., Smith, A., Anaya, J. M., Miura, T. et al., CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat. Immunol. 2007. 8: 1324-1336.
38. Ahuja, S. K., Kulkarni, H., Catano, G., Agan, B. K., Camargo, J. F., He, W., O'Connell, R. J. et al., CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat. Med. 2008. 14: 413-420.
39. Urban, T. J., Weintrob, A. C., Fellay, J., Colombo, S., Shianna, K. V., Gumbs, C., Rotger, M. et al., CCL3L1 and HIV/AIDS susceptibility. Nat. Med. 2009. 15: 1110-1112.
40. Bhattacharya, T., Stanton, J., Kim, E. Y., Kunstman, K. J., Phair, J. P., Jacobson, L. P. and Wolinsky, S. M., CCL3L1 and HIV/AIDS susceptibility. Nat. Med. 2009. 15: 1112-1115.
41. McKinney, C., Merriman, M. E., Chapman, P. T., Gow, P. J., Harrison, A. A., Highton, J., Jones, P. B. et al., Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann. Rheumat. Dis. 2008. 67: 409-413.
42. Carpenter, D., Walker, S., Prescott, N., Schalkwijk, J. and Armour, J. A., Accuracy and differential bias in copy number measurement of CCL3L1 in association studies with three auto-immune disorders. BMC Genom. 2011. 12: 418. DOI: 10.1186/1471-2164-12-418.
43. Mamtani, M., Rovin, B., Brey, R., Camargo, J. F., Kulkarni, H., Herrera, M., Correa, P. y CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann. Rheumat. Dis. 2008. 67: 1076-1083.
44. He, W., Kulkarni, H., Castiblanco, J., Shimizu, C., Aluyen, U., Maldonado, R., Carrillo, A. et al., Reply to: "experimental aspects of copy number variant assays at CCL3L1". Nat. Med. 2009. 15: 1117-1120.
45. Field, S. F., Howson, J. M., Maier, L. M., Walker, S., Walker, N. M., Smyth, D. J., Armour, J. A. et al., Experimental aspects of copy number variant assays at CCL3L1. Nat. Med. 2009. 15: 1115-1117.
46. Pickering, M. C., Botto, M., Taylor, P. R., Lachmann, P. J. and Walport, M. J., Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 2000. 76: 227-324.
47. Yang, Y., Chung, E. K., Wu, Y. L., Savelli, S. L., Nagaraja, H. N., Zhou, B., Hebert, M. et al., Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am. J. Hum. Genet. 2007. 80: 1037-1054.
48. Lv, Y., He, S., Zhang, Z., Li, Y., Hu, D., Zhu, K., Cheng, H. et al., Confirmation of C4 gene copy number variation and the association with systemic lupus erythematosus in Chinese Han population. Rheumatol. Int. 2011. DOI: 10.1007/s00296-011-2023-7.
49. Rigby, W. F., Wu, Y. L., Zan, M., Zhou, B., Rosengren, S., Carlson, C., Hilton, W. et al., Increased frequency of complement C4B deficiency in rheumatoid arthritis. Arthritis and Rheum. 2011. 64: 1338-1344.
50. Boteva, L., Morris, D. L., Cortes-Hernandez, J., Martin, J., Vyse, T. J. and Fernando, M. M., Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. Am. J. Hum. Genet. 2012. 90: 445-456.
51. Antonell, A., de Luis, O., Domingo-Roura, X. and Perez-Jurado, L. A., Evolutionary mechanisms shaping the genomic structure of the Williams-Beuren syndrome chromosomal region at human 7q11.23. Genome Res. 2005. 15: 1179-1188.
52. Bayes, M., Magano, L. F., Rivera, N., Flores, R. and Perez Jurado, L. A., Mutational mechanisms of Williams-Beuren syndrome deletions. Am. J. Hum. Genet. 2003. 73: 131-151.
53. Gorlach, A., Lee, P. L., Roesler, J., Hopkins, P. J., Christensen, B., Green, E. D., Chanock, S. J. et al., A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease. J. Clin. Invest. 1997. 100: 1907-1918.
54. Heyworth, P. G., Noack, D. and Cross, A. R., Identification of a novel NCF-1 (p47-phox) pseudogene not containing the signature GT deletion: significance for A47 degrees chronic granulomatous disease carrier detection. Blood 2002. 100: 1845-1851.
55. Olsson, L. M., Nerstedt, A., Lindqvist, A. K., Johansson, A. C., Medstrand, P., Olofsson, P. and Holmdahl, R., Copy number variation of the gene NCF1 is associated with rheumatoid arthritis. Antioxid. Redox. Signal 2011. 16: 71-78.
56. Hultqvist, M., Olsson, L. M., Gelderman, K. A. and Holmdahl, R., The protective role of ROS in autoimmune disease. Trends Immunol. 2009. 30: 201-208.
57. Hultqvist, M., Sareila, O., Vilhardt, F., Norin, U., Olsson, L. M., Olofsson, P., Hellman, U. et al., Positioning of a polymorphic quantitative trait nucleotide in the Ncf1 gene controlling oxidative burst response and arthritis severity in rats. Antioxid. Redox. Signal 2011. 14: 2373-2383.
58. Jacob, C. O., Eisenstein, M., Dinauer, M. C., Ming, W., Liu, Q., John, S., Quismorio, F. P., Jr. et al., Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc. Natl. Acad. Sci. USA 2012. 109: E59-E67.
59. Rioux, J. D., Xavier, R. J., Taylor, K. D., Silverberg, M. S., Goyette, P., Huett, A., Green, T. et al., Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 2007. 39: 596-604.
60. Sawcer, S., Hellenthal, G., Pirinen, M., Spencer, C. C., Patsopoulos, N. A., Moutsianas, L., Dilthey, A. et al., Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011. 476: 214-219.
61. Olsson, L. M., Lindqvist, A. K., Kallberg, H., Padyukov, L., Burkhardt, H., Alfredsson, L., Klareskog, L. et al., A case-control study of rheumatoid arthritis identifies an associated SNP in the NCF4 gene supporting a role for the NOX-complex in autoimmunity. Arthritis Res. Ther. 2007. 9: R98. DOI: 10.1186/ar2299.